Zymedyne Therapeutics is pleased to announce that it has been awarded an Entrepreneurship Seed grant from Campus Alberta Neuroscience (CAN).
This CAN program supports “neuroscience related innovation and entrepreneurship efforts in Alberta through direct funding and commercialization support”.
For more information on the CAN program go to:
